Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol CEO says Gilead holding out on hep C tie-up
Bristol CEO says Gilead holding out on hep C tie-up
Bristol CEO says Gilead holding out on hep C tie-up
Submitted by
admin
on June 1, 2012 - 12:30pm
Source:
Fierce Biotech
News Tags:
Bristol-Myers Squibb
Gilead
hepatitis C
Lamberto Andreotti
daclatasvir
GS-7977
Headline:
Bristol CEO says Gilead holding out on hep C tie-up
Do Not Allow Advertisers to Use My Personal information
